They already have 1.5mg/kg x 2 in the Stage 1 protocol.
This may end up being replaced with 2mg/kg x 2 given safety concerns over rat studies has been comprehensively dealt with since.
Remember the DMC will decide the final dosage protocol to be used for OA002 based on statistical significance of Stage 1 protocols. Interim results of Stage 1 are suggesting they will be accommodating to this request to revise the dosage protocols back to the preferred 2mg/kg. This optimal dosage is supported by all historical studies as being statistically significant with clinical meaningful effect size per (008, SAS, 2B, NFL etc). The chance of 2mg/kg x 2 not repeating the same or equivalent results are less than extremely remote. Those looking at the actual data will understand this point better than most of us on here.
- Forums
- ASX - By Stock
- PAR
- Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS
Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS, page-117
-
- There are more pages in this discussion • 121 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $70.04M |
Open | High | Low | Value | Volume |
20.5¢ | 21.0¢ | 20.0¢ | $158.9K | 781.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 198291 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 20781 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 155960 | 0.200 |
11 | 180704 | 0.195 |
19 | 264984 | 0.190 |
6 | 132240 | 0.185 |
15 | 730784 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 20781 | 4 |
0.210 | 137179 | 6 |
0.215 | 220442 | 7 |
0.220 | 89060 | 8 |
0.225 | 38509 | 4 |
Last trade - 14.31pm 10/10/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online